David Domzalski - 31 Dec 2021 Form 4 Insider Report for VYNE Therapeutics Inc. (VYNE)

Role
President and CEO, Director
Signature
/s/ Mutya Harsch, attorney-in-fact for David Domzalski
Issuer symbol
VYNE
Transactions as of
31 Dec 2021
Net transactions value
-$7,025
Form type
4
Filing time
04 Jan 2022, 15:39:28 UTC
Previous filing
02 Dec 2021
Next filing
18 Mar 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction VYNE Common Stock Tax liability $7,025 -6,887 -0.9% $1.02 760,633 31 Dec 2021 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares that have been withheld by the Issuer to satisfy tax withholding requirements in connection with the vesting of restricted stock units.